دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation
Jörg Hausleiter, MD, a D. Scott Lim, MD,b Linda D. Gillam, MD, MPH,c Firas Zahr, MD, d Scott Chadderdon, MD, d Andrew N. Rassi, MD, e Raj Makkar, MD,f Scott Goldman, MD, g Volker Rudolph, MD,h James Hermiller, MD,i Robert M. Kipperman, MD,c Abhijeet Dhoble, MD,j Richard Smalling, MD,j Azeem Latib, MD,k Susheel K. Kodali, MD, l Mohamad Lazkani, MD,m Joseph Choo, MD,n Philipp Lurz, MD, PH D, o William W. O’Neill, MD,p Roger Laham, MD,q Josep Rodés-Cabau, MD, r Saibal Kar, MD, s Niklas Schofer, MD,t Brian Whisenant, MD, u Ignacio Inglessis-Azuaje, MD,v Stephan Baldus, MD,w Samir Kapadia, MD,x Konstantinos Koulogiannis, MD,c Leo Marcoff, MD,c Robert L. Smith, MD,y on behalf of the PASCAL IID Registry Investigators
doi : 10.1016/j.jacc.2022.11.034
Volume 81, Issue 5, 7 February 2023, Pages 431-442
Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation With Complex Mitral Valve Anatomy∗
Megan S. Joseph, MD, David S. Bach, MD
doi : 10.1016/j.jacc.2022.11.033
Volume 81, Issue 5, 7 February 2023, Pages 443-445
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest
Alessandro Spirito, MD,a,b Lukas Vaisnora, MD,a Athanasios Papadis, MD,a Fortunato Iacovelli, MD, PH D, c Celestino Sardu, MD, MS, PHD, d Alexandra Selberg, MA, b Sarah Bär, MD,a Raminta Kavaliauskaite, MD,a Fabrice Temperli, MD, a Babken Asatryan, MD, P HD, a Thomas Pilgrim, MD, a Lukas Hunziker, MD, a Dik Heg, P HD, e Marco Valgimigli, MD, PH D, f Stephan Windecker, MD,a Lorenz Räber, MD, PHD
doi : 10.1016/j.jacc.2022.10.039
Volume 81, Issue 5, 7 February 2023, Pages 446-456
Timely Reperfusion for Everyone…Except for Some Out-of-Hospital Cardiac Arrest Patients?∗
Karl B. Kern, MD
doi : 10.1016/j.jacc.2022.11.035
Volume 81, Issue 5, 7 February 2023, Pages 457-459
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Mikhail N. Kosiborod, MD,a, * Ankeet S. Bhatt, MD, MBA, b,c, * Brian L. Claggett, PH D, b Muthiah Vaduganathan, MD, MPH,b Ian J. Kulac, MS, b Carolyn S.P. Lam, MD,d Adrian F. Hernandez, MD,e Felipe A. Martinez, MD, f Silvio E. Inzucchi, MD,g Sanjiv J. Shah, MD, h Rudolf A. de Boer, MD, i Pardeep S. Jhund, MBC H B, MS C, P HD, j Akshay S. Desai, MD, MPH,b James C. Fang, MD, k Yaling Han, MD, PHD, l Josep Comin-Colet, MD, PHD, m Orly Vardeny, PHARMD, MS,n Daniel Lindholm, MD, PHD, o Ulrica Wilderäng, P HD, n Olof Bengtsson, P HLIC, o John J.V. McMurray, MD, j Scott D. Solomon, MD
doi : 10.1016/j.jacc.2022.11.006
Volume 81, Issue 5, 7 February 2023, Pages 460-473
Patients with heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) experience a high burden of symptoms, physical limitations, and poor quality of life; improving health status is a key goal of management.
Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction∗
William S. Weintraub, MD
doi : 10.1016/j.jacc.2022.11.032
Volume 81, Issue 5, 7 February 2023, Pages 474-476
Phenotypes of Overdiagnosed Long QT Syndrome
Sahej Bains, BS, a,b, * Raquel Neves, MD, b, * J. Martijn Bos, MD, PHD, b,c,d John R. Giudicessi, MD, PHD, d Ciorsti MacIntyre, MD, d Michael J. Ackerman, MD, P HD b,
doi : 10.1016/j.jacc.2022.11.036
Volume 81, Issue 5, 7 February 2023, Pages 477-486
Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers∗
Arthur A.M. Wilde, MD, PH D, a,b,c Peter J. Schwartz, MD c,d
doi : 10.1016/j.jacc.2022.11.037
Volume 81, Issue 5, 7 February 2023, Pages 487-489
Challenges in Cardiovascular Evaluation and Management of Obese Patients: JACC State-of-the-Art Review
Rosana G. Bianchettin, MD,a Carl J. Lavie, MD,b Francisco Lopez-Jimenez, MD
doi : 10.1016/j.jacc.2022.11.031
Volume 81, Issue 5, 7 February 2023, Pages 490-504
Many unique clinical challenges accompany the diagnosis and treatment of cardiovascular disease (CVD) in people living with overweight/obesity. Similarly, physicians encounter numerous complicating factors when managing obesity among people with CVD.
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week
William E. Boden, MD,a,b Mario Marzilli, MD, c Filippo Crea, MD,d G.B. John Mancini, MD,e William S. Weintraub, MD,f Viviany R. Taqueti, MD, MPH,g Carl J. Pepine, MD,h Javier Escaned, MD, P HD, i Rasha Al-Lamee, MBBS, MA, j Luis Henrique W. Gowdak, MD, k Colin Berry, MD, PHD, l Juan Carlos Kaski, DSC, MD, m on behalf of the Chronic Myocardial Ischemic Syndromes Task Force
doi : 10.1016/j.jacc.2022.08.814
Volume 81, Issue 5, 7 February 2023, Pages 505-514
Management of stable coronary artery disease (CAD) has been based on the assumption that flow-limiting atherosclerotic obstructions are the proximate cause of angina and myocardial ischemia in most patients and represent an important target for revascularization.
JACC: Advances: The Making of a Community
Candice K. Silversides, MD, MS, Editor-in-Chief, JACC: Advances Valentin Fuster, MD, PH D,
doi : 10.1016/j.jacc.2022.12.013
Volume 81, Issue 5, 7 February 2023, Pages 515-516
10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension
Hussam Al Ghorani, MD Saarraaken Kulenthiran, MD Michael Johannes Maria Recktenwald Lucas Lauder, MD Michael Kunz, MD Felix Götzinger, MD Sebastian Ewen, MD Christian Ukena, MD Michael Böhm, MD Felix Mahfoud, MD, MA *Klinik für Innere Medizin III
doi : 10.1016/j.jacc.2022.11.038
Volume 81, Issue 5, 7 February 2023, Pages 517-519
Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation
Jörg Hausleiter, MD, a D. Scott Lim, MD,b Linda D. Gillam, MD, MPH,c Firas Zahr, MD, d Scott Chadderdon, MD, d Andrew N. Rassi, MD, e Raj Makkar, MD,f Scott Goldman, MD, g Volker Rudolph, MD,h James Hermiller, MD,i Robert M. Kipperman, MD,c Abhijeet Dhoble, MD,j Richard Smalling, MD,j Azeem Latib, MD,k Susheel K. Kodali, MD, l Mohamad Lazkani, MD,m Joseph Choo, MD,n Philipp Lurz, MD, PH D, o William W. O’Neill, MD,p Roger Laham, MD,q Josep Rodés-Cabau, MD, r Saibal Kar, MD, s Niklas Schofer, MD,t Brian Whisenant, MD, u Ignacio Inglessis-Azuaje, MD,v Stephan Baldus, MD,w Samir Kapadia, MD,x Konstantinos Koulogiannis, MD,c Leo Marcoff, MD,c Robert L. Smith, MD,y on behalf of the PASCAL IID Registry Investigators
doi : 10.1016/j.jacc.2022.11.034
Volume 81, Issue 5, 7 February 2023, Pages 431-442
Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation With Complex Mitral Valve Anatomy∗
Megan S. Joseph, MD, David S. Bach, MD
doi : 10.1016/j.jacc.2022.11.033
Volume 81, Issue 5, 7 February 2023, Pages 443-445
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest
Alessandro Spirito, MD,a,b Lukas Vaisnora, MD,a Athanasios Papadis, MD,a Fortunato Iacovelli, MD, PH D, c Celestino Sardu, MD, MS, PHD, d Alexandra Selberg, MA, b Sarah Bär, MD,a Raminta Kavaliauskaite, MD,a Fabrice Temperli, MD, a Babken Asatryan, MD, P HD, a Thomas Pilgrim, MD, a Lukas Hunziker, MD, a Dik Heg, P HD, e Marco Valgimigli, MD, PH D, f Stephan Windecker, MD,a Lorenz Räber, MD, PHD
doi : 10.1016/j.jacc.2022.10.039
Volume 81, Issue 5, 7 February 2023, Pages 446-456
Timely Reperfusion for Everyone…Except for Some Out-of-Hospital Cardiac Arrest Patients?∗
Karl B. Kern, MD
doi : 10.1016/j.jacc.2022.11.035
Volume 81, Issue 5, 7 February 2023, Pages 457-459
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Mikhail N. Kosiborod, MD,a, * Ankeet S. Bhatt, MD, MBA, b,c, * Brian L. Claggett, PH D, b Muthiah Vaduganathan, MD, MPH,b Ian J. Kulac, MS, b Carolyn S.P. Lam, MD,d Adrian F. Hernandez, MD,e Felipe A. Martinez, MD, f Silvio E. Inzucchi, MD,g Sanjiv J. Shah, MD, h Rudolf A. de Boer, MD, i Pardeep S. Jhund, MBC H B, MS C, P HD, j Akshay S. Desai, MD, MPH,b James C. Fang, MD, k Yaling Han, MD, PHD, l Josep Comin-Colet, MD, PHD, m Orly Vardeny, PHARMD, MS,n Daniel Lindholm, MD, PHD, o Ulrica Wilderäng, P HD, n Olof Bengtsson, P HLIC, o John J.V. McMurray, MD, j Scott D. Solomon, MD
doi : 10.1016/j.jacc.2022.11.006
Volume 81, Issue 5, 7 February 2023, Pages 460-473
Patients with heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) experience a high burden of symptoms, physical limitations, and poor quality of life; improving health status is a key goal of management.
Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction∗
William S. Weintraub, MD
doi : 10.1016/j.jacc.2022.11.032
Volume 81, Issue 5, 7 February 2023, Pages 474-476
Phenotypes of Overdiagnosed Long QT Syndrome
Sahej Bains, BS, a,b, * Raquel Neves, MD, b, * J. Martijn Bos, MD, PHD, b,c,d John R. Giudicessi, MD, PHD, d Ciorsti MacIntyre, MD, d Michael J. Ackerman, MD, P HD b,
doi : 10.1016/j.jacc.2022.11.036
Volume 81, Issue 5, 7 February 2023, Pages 477-486
Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers∗
Arthur A.M. Wilde, MD, PH D, a,b,c Peter J. Schwartz, MD c,d
doi : 10.1016/j.jacc.2022.11.037
Volume 81, Issue 5, 7 February 2023, Pages 487-489
Challenges in Cardiovascular Evaluation and Management of Obese Patients: JACC State-of-the-Art Review
Rosana G. Bianchettin, MD,a Carl J. Lavie, MD,b Francisco Lopez-Jimenez, MD
doi : 10.1016/j.jacc.2022.11.031
Volume 81, Issue 5, 7 February 2023, Pages 490-504
Many unique clinical challenges accompany the diagnosis and treatment of cardiovascular disease (CVD) in people living with overweight/obesity. Similarly, physicians encounter numerous complicating factors when managing obesity among people with CVD.
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week
William E. Boden, MD,a,b Mario Marzilli, MD, c Filippo Crea, MD,d G.B. John Mancini, MD,e William S. Weintraub, MD,f Viviany R. Taqueti, MD, MPH,g Carl J. Pepine, MD,h Javier Escaned, MD, P HD, i Rasha Al-Lamee, MBBS, MA, j Luis Henrique W. Gowdak, MD, k Colin Berry, MD, PHD, l Juan Carlos Kaski, DSC, MD, m on behalf of the Chronic Myocardial Ischemic Syndromes Task Force
doi : 10.1016/j.jacc.2022.08.814
Volume 81, Issue 5, 7 February 2023, Pages 505-514
Management of stable coronary artery disease (CAD) has been based on the assumption that flow-limiting atherosclerotic obstructions are the proximate cause of angina and myocardial ischemia in most patients and represent an important target for revascularization.
JACC: Advances: The Making of a Community
Candice K. Silversides, MD, MS, Editor-in-Chief, JACC: Advances Valentin Fuster, MD, PH D,
doi : 10.1016/j.jacc.2022.12.013
Volume 81, Issue 5, 7 February 2023, Pages 515-516
10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension
Hussam Al Ghorani, MD Saarraaken Kulenthiran, MD Michael Johannes Maria Recktenwald Lucas Lauder, MD Michael Kunz, MD Felix Götzinger, MD Sebastian Ewen, MD Christian Ukena, MD Michael Böhm, MD Felix Mahfoud, MD, MA *Klinik für Innere Medizin III
doi : 10.1016/j.jacc.2022.11.038
Volume 81, Issue 5, 7 February 2023, Pages 517-519
